Commentary: Chemo if you can-disparities in receipt of guideline-concordant adjuvant therapy in patients with locoregional non-small cell lung cancer

J Thorac Cardiovasc Surg. 2020 Jul;160(1):273-274. doi: 10.1016/j.jtcvs.2019.12.035. Epub 2020 Jan 3.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • Combined Modality Therapy
  • Healthcare Disparities
  • Humans
  • Lung Neoplasms*